Immutep LimitedIMMPNASDAQ

52-Week Range0-4

0.40Current 0.413.53

Want to monitor IMMP?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

Gross Margin

Operating Margin

Revenue Growth

immutep is a globally active biotechnology company, listed on the australian stock exchange and on the nasdaq global market in the us.

Professional, Scientific, and Technical Services

Research and Development in Biotechnology (except Nanobiotechnology)

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance

Alerts

News

uCloudlink Group Inc. Sponsored ADR (UCL) Reports Q4 Loss, Misses Revenue Estimates

2 Stocks I'm Buying for the Future of AI Work

Protagonist Therapeutics Announces U.S. FDA Approval of ICOTYDE(TM) (icotrokinra) for the Treatment of Moderate to Severe Plaque Psoriasis

NAPC Defense, Inc. Positioned as Primary Subcontractor on Obera Portfolio Following Asset Acquisition by Native American Pride Constructors, LLC

Blue Lagoon's Milling Partner has Processed 3,000 Tonnes of Dome Mountain Material Producing Over 210 Tonnes of Gold & Silver Concentrate

PDD Holdings to Report Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results on March 25, 2026

Akari Therapeutics Announces Abstract Accepted for Poster Presentation at the American Association for Cancer Research Annual Meeting 2026

Kraft Heinz Has Free Cash Flow but Losing Consumers to Store Brands Is the Real Problem

The $2,000 Drug Cap Is Saving Medicare Retirees Over $1,500 a Year Right Now

SEC Approved XRP ETFs That Let You Ride The Crypto Boom

Gilat Defense, AWS, SES Space & Defense and WAVE Consortium Demonstrate Virtualized SATCOM Gateway Modem Architecture at Satellite 2026

Betting Against Semiconductors: Contrarian Play of Sucker Play?

Jabil Stock Is Rising. The AI Darling Beats Earnings Expectations.

Mayo not today: Unilever's foods dilemma splits the analysts

Transpetro expands shipping clients beyond Petrobras, signs deals with Trafigura, Ipiranga

60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification (NDIN) with FDA for Australian Chestnut Extract

Macy's proves Wall Street wrong again by growing sales, and the stock surges

Bear of the Day: Grid Dynamics (GDYN)

Bull of the Day: Sanmina (SANM)

GSK Expanding Fast - Oncology, HIV, And Smart Acquisitions

About